Effectiveness of Antibiotic Prophylaxis in Preventing Postoperative Infection Following Total Knee Arthroplasty: A Systematic Review

Document Type : Systematic Review

Authors

1 Assistant Professor of Orthopaedics, Department of Orthopedics, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

2 Department of Infectious Disease, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

10.22034/mphrj.2026.587088.1104
Abstract
Introduction: Total knee arthroplasty is an effective treatment for advanced knee disorders but remains vulnerable to postoperative infections, including periprosthetic joint infection, which can lead to serious complications and increased healthcare burden. Antibiotic prophylaxis is widely used to reduce this risk, yet optimal strategies remain debated. Therefore, this study aims to systematically review the evidence regarding the effectiveness of antibiotic prophylaxis in preventing infection following TKA.

Material and methods: This systematic review was conducted according to PRISMA guidelines. Eligible studies included randomized and observational research evaluating antibiotic prophylaxis in adult patients undergoing total knee arthroplasty with reported postoperative infection outcomes. Multiple databases were searched using MeSH terms and related keywords by two independent reviewers. Study quality was assessed using the Newcastle–Ottawa Scale and the Cochrane Risk of Bias tool.

Results: The literature search identified 851 records, of which nine studies met the inclusion criteria after screening and full text assessment. Overall, intravenous antibiotic regimens demonstrated moderate to high treatment success across studies, with reported success rates ranging from 63% to 90% and follow up durations varying between 3.5 and 72 months. Most regimens involved glycopeptide or rifampicin based therapies administered for approximately 2–6 weeks, with generally favorable clinical outcomes.

Conclusion: The available evidence suggests that intravenous antibiotic therapy provides generally favorable outcomes in the management of infection related complications. Across the included studies, treatment success was consistently moderate to high despite variations in antimicrobial regimens, treatment duration, and follow up periods. Glycopeptide and rifampicin based therapies appear to play a central role in achieving effective infection control.

Graphical Abstract

Effectiveness of Antibiotic Prophylaxis in Preventing Postoperative Infection Following Total Knee Arthroplasty: A Systematic Review

Keywords

Subjects

[1]                Barros, L. H., Barbosa, T. A., Esteves, J., Abreu, M., Soares, D., & Sousa, R. (2019). Early debridement, antibiotics and implant retention (DAIR) in patients with suspected acute infection after hip or knee arthroplasty safe, effective and without negative functional impact. Journal of Bone and Joint Infection, *4*(6), 300–305.
[2]                Chalmers, B. P., Kapadia, M., Chiu, Y. F., Miller, A. O., Henry, M. W., Lyman, S., & Westrich, G. H. (2021). Accuracy of predictive algorithms in total hip and knee arthroplasty acute periprosthetic joint infections treated with debridement, antibiotics, and implant retention (DAIR). The Journal of Arthroplasty, *36*(7), 2558–2564.
[3]                Chang, Y. J., Lee, M. S., Lee, C. H., Lin, P. C., & Kuo, F. C. (2017). Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection. BMC Infectious Diseases, *17*(1), 736.
[4]                Estes, C. S., Beauchamp, C. P., Clarke, H. D., & Spangehl, M. J. (2010). A two-stage retention debridement protocol for acute periprosthetic joint infections. Clinical Orthopaedics and Related Research, *468*(8), 2029–2038.
[5]                Fink, B., Schuster, P., Schwenn Inger, C., Frommelt, L., & Oremek, D. (2017). A standardized regimen for the treatment of acute postoperative infections and acute hematogenous infections associated with hip and knee arthroplasties. The Journal of Arthroplasty, *32*(4), 1255–1261.
[6]                Haddad, F. S., Sukeik, M., & Alazzawi, S. (2015). Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clinical Orthopaedics and Related Research, *473*(1), 8–14.
[7]                Klement, M. R., Cunningham, D. J., Wooster, B. M., Wellman, S. S., Bolognesi, M. P., Green, C. L., & Seyler, T. M. (2019). Comparing standard versus extended culture duration in acute hip and knee periprosthetic joint infection. Journal of the American Academy of Orthopaedic Surgeons, *27*(10), e437–e443.
[8]                Longo, U. G., Ciuffreda, M., Mannering, N., D'Andrea, V., Locher, J., Salvatore, G., & Denaro, V. (2018). Outcomes of posterior-stabilized compared with cruciate-retaining total knee arthroplasty. The Journal of Knee Surgery, *31*(4), 321–340.
[9]                Manrique, J., Komnos, G. A., Tan, T. L., Sedgh, S., Shohat, N., & Parvizi, J. (2019). Outcomes of superficial and deep irrigation and debridement in total hip and knee arthroplasty. The Journal of Arthroplasty, *34*(7), 1452–1457.
[10]             Masri, B. A., Panagiotopoulos, K. P., Greidanus, N. V., Garbuz, D. S., & Duncan, C. P. (2007). Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. The Journal of Arthroplasty, *22*(1), 72–78.
[11]             Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLOS Medicine, *6*(7), e1000097.
[12]             Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, *372*, n71.
[13]             Riesgo, A. M., Park, B. K., Herrero, C. P., Yu, S., Schwarzkopf, R., & Iorio, R. (2018). Vancomycin povidone-iodine protocol improves survivorship of periprosthetic joint infection treated with irrigation and debridement. The Journal of Arthroplasty, *33*(3), 847–850.
[14]             Rudelli, B. A., Giglio, P. N., de Carvalho, V. C., Pécora, J. R., Gurgel, H. M. C., Gobbi, R. G., & Lima, A. L. L. M. (2020). Bacteria drug resistance profile affects knee and hip periprosthetic joint infection outcome with debridement, antibiotics and implant retention. BMC Musculoskeletal Disorders, *21*(1), 574.
[15]             Sandeep, M. (2017). Chapter 7: Systematic reviews of etiology and risk. In E. Aromataris & Z. Munn (Eds.), Joanna Briggs Institute reviewer's manual. The Joanna Briggs Institute.
[16]             Srivastava, K., Bozic, K. J., Silverton, C., Nelson, A. J., Makhni, E. C., & Davis, J. J. (2019). Reconsidering strategies for managing chronic periprosthetic joint infection in total knee arthroplasty: Using decision analytics to find the optimal strategy between one-stage and two-stage total knee revision. The Journal of Bone and Joint Surgery (American Volume), *101*(1), 14–24.
[17]             Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., ... & Higgins, J. P. (2016). ROBINS-I: A tool for assessing risk of bias in non-randomized studies of interventions. BMJ, *355*, i4919.
[18]             Tirumala, V., Smith, E., Box, H., van den Kieboom, J., Klemt, C., & Kwon, Y. M. (2021). Outcome of debridement, antibiotics, and implant retention with modular component exchange in acute culture-negative periprosthetic joint infections. The Journal of Arthroplasty, *36*(3), 1087–1093.
[19]             Van Kleunen, J. P., Knox, D., Garino, J. P., & Lee, G. C. (2010). Irrigation and debridement and prosthesis retention for treating acute periprosthetic infections. Clinical Orthopaedics and Related Research, *468*(8), 2024–2028.
[20]             Veerman, K., Raessens, J., Telgt, D., Smulders, K., & Goosen, J. H. M. (2022). Debridement, antibiotics, and implant retention after revision arthroplasty: Antibiotic mismatch, timing, and repeated DAIR associated with poor outcome. The Bone & Joint Journal, *104-B*(4), 464–471.